基本資料
種類: ETF
費用比率%: --
資產淨值: 24.69
成立日期: 16/09/2026
 
分析
市值分佈:
79.56%
大市值
15.76%
中市值
2.86%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/11/2026 05:47) 總持有投資項目: 88  
0%
 
100%
     10大 (28.31%)
代號 名稱 佔比% ▼ 持有日期
ARGXargenx SE5.0731/10/2026
KYMRKymera Therapeutics4.0130/09/2026
KODKodiak Sciences2.8231/10/2026
INSMInsmed Incorporated2.5831/10/2026
UTHRUnited Therapeutics Corp2.4431/10/2026
NTRANatera2.4330/09/2026
VRTXVertex Pharmaceuticals2.4331/10/2026
RVMDRevolution Medicines2.2331/10/2026
MRNAModerna2.2131/10/2026
PCVXVaxcyte2.0931/10/2026
BBIOBridgeBio Pharma2.0831/10/2026
SYRESpyre Therapeutics1.9531/10/2026
DNTHDianthus Therapeutics1.9030/09/2026
PRAXPraxis Precision Medicines1.8931/10/2026
RYTMRhythm Pharmaceuticals1.7731/10/2026
CYTKCytokinetics1.7631/10/2026
ALKSAlkermes plc1.7431/10/2026
CGONCG Oncology1.7330/09/2026
MIRMMirum Pharmaceuticals1.6531/10/2026
SRRKScholar Rock Holding Corp1.6330/09/2026
 1    2    3    4    5  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.